v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (3,292,452) $ (1,757,914)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 2,518
Net loss on disposal of securities 340,408
Amortization of contract asset 258,144
Amortization of prepaid consulting (Series B Preferred Stock) 84,374
Issuance cost from the sale of the ELOC 210,109
Stock compensation expense 100,431 783,762
Lease expense (10,272) (2,172)
Change in the fair value of deferred consideration (120,040)
Credit benefit (702,695)
Change in fair value of warrant (31,197) (1,254,240)
Changes in operating assets and liabilities:    
Accounts receivable – trade 10,366 83,674
Accounts receivable – related party 325,596 385,168
Prepaid expenses 438,166 317,545
Accrued interest receivable 14,214
Other assets (173,645) (286,672)
Other current liabilities (217,690) (58,370)
Accounts payable 340,570 486,818
Accounts payable – related party (12,640) 89,309
Accrued expenses (486,294) (480,811)
Contract liabilities (18,127)
Deferred revenue (15,415)
Net cash used in operating activities (2,834,136) (1,815,338)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from sale and redemption of preferred securities 654,904
Net proceeds from loan repayment 6,545
Net cash provided by investing activities 654,904 6,545
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from the sale of Class A common stock 1,129,768
Repayment of senior secured promissory note (255,765)
Net share settlement for stock compensation expense (12,771)
Net cash provided by (used in) financing activities 1,129,768 (268,536)
Net decrease in cash and cash equivalents (1,049,464) (2,077,329)
Cash and cash equivalents – beginning of period 6,779,040 2,324,647
Cash and cash equivalents – end of period 5,729,576 247,318
Supplemental Disclosure of Non-Cash Investing and Financing Activities    
Reclassification of forward purchase receivable (4,584,221)
Receivable for unsettled ADTX sale 454,688
Forfeiture of Series B shares related to consulting contract 72,148
Accrued redemption payable to Series B holders 295,022
Interest paid $ 6,870 $ 228,901